Recent

% | $
Quotes you view appear here for quick access.

Oncolytics Biotech, Inc. Message Board

  • nomenome91 nomenome91 Dec 7, 2012 2:44 PM Flag

    Ovarian NCI trial just updated

    The end date for the trial was just set to Sept 2019. This is not a mistake because they recently restated the monitoring period to be five years.

    The OS for the patient profile they are working with is about 14 months for both Doxil and Topotecan. Does this mean they expect to monitor the last patient 7 years from now?

    Why did Brad and Matt sound so confident in saynig REO will registered in 2014? The Head and neck registration trial hasn't even been started. What do they know?

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ONCY
0.330.00(0.00%)Nov 4 4:00 PMEST